Beam Therapeutics Inc. SEC filings BEAM
Beam Therapeutics Inc. has 514 filings in SEC EDGAR's recent list, going back to Aug 9, 2018. Its latest annual report, Form ARS, was filed on Apr 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 3, 2026 | Nov 3, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2026 | Aug 4, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 8, 2026 | Jun 3, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 8-K |
Current report
Agreement ended
|
Mar 5, 2026 | Mar 2, 2026 |
| 8-K |
Current report
Material agreement, Results of operations, New debt
|
Feb 24, 2026 | Feb 24, 2026 |
| 8-K |
Current report
Material agreement
|
Feb 12, 2026 | Feb 9, 2026 |
| 8-K |
Current report
Officer or director change
|
Feb 5, 2026 | Jan 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 12, 2026 | Jan 11, 2026 |
| 8-K |
Current report
Acquisition or sale of assets
|
Dec 11, 2025 | Dec 8, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2025 | Nov 4, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2025 | Aug 5, 2025 |
| 8-K |
Current report
Unregistered share sale
|
Jul 3, 2025 | Jul 1, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2025 | Jun 4, 2025 |
| 8-K |
Current report
Results of operations
|
May 6, 2025 | May 6, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Mar 10, 2025 | Mar 10, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 10, 2025 | Mar 10, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 25, 2025 | Feb 25, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 9, 2024 | Dec 7, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 6, 2024 | Dec 5, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 4, 2024 | Dec 2, 2024 |
| 8-K |
Current report
Other events
|
Nov 5, 2024 | Nov 5, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 5, 2024 | Nov 5, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2024 | Nov 5, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 15, 2024 | Jul 11, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Results of operations
|
May 7, 2024 | May 7, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2024 | Feb 27, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Officer or director change
|
Dec 14, 2023 | Dec 13, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2023 | Nov 8, 2023 |
| 8-K |
Current report
Acquisition or sale of assets, Unregistered share sale, Other events
|
Oct 31, 2023 | Oct 27, 2023 |
| 8-K |
Current report
Exit or restructuring costs, Regulation FD disclosure, Other events
|
Oct 19, 2023 | Oct 18, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 8, 2023 | Jun 6, 2023 |
| 8-K |
Current report
Material agreement
|
May 10, 2023 | May 10, 2023 |
| 8-K |
Current report
Results of operations
|
May 10, 2023 | May 10, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2023 | Feb 28, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2022 | Nov 7, 2022 |
| 8-K |
Current report
Other events
|
Sep 7, 2022 | Sep 2, 2022 |
| 8-K |
Current report
Other events
|
Aug 30, 2022 | Aug 25, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2022 | Aug 9, 2022 |
| 8-K |
Current report
Other events
|
Aug 1, 2022 | Aug 1, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2022 | Jun 8, 2022 |
| 8-K |
Current report
Results of operations
|
May 9, 2022 | May 9, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2022 | Feb 28, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 10, 2022 | Jan 9, 2022 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Nov 8, 2021 | Nov 5, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2021 | Aug 10, 2021 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 7, 2021 | Jul 7, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2021 | Jun 9, 2021 |
| 8-K |
Current report
Officer or director change
|
May 24, 2021 | May 20, 2021 |
| 8-K |
Current report
Results of operations
|
May 11, 2021 | May 11, 2021 |
| 8-K |
Current report
Officer or director change
|
Apr 23, 2021 | Apr 22, 2021 |
| 8-K |
Current report
Other events
|
Apr 1, 2021 | Apr 1, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 15, 2021 | Mar 15, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Feb 23, 2021 | Feb 22, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jan 19, 2021 | Jan 16, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2021 | Jan 12, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 12, 2021 | Jan 12, 2021 |
| 8-K |
Current report
Officer or director change
|
Jan 11, 2021 | Jan 10, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2020 | Nov 10, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2020 | Aug 12, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 29, 2020 | Jun 29, 2020 |
| 8-K |
Current report
Results of operations
|
May 12, 2020 | May 12, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2020 | Mar 30, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Feb 11, 2020 | Feb 10, 2020 |
Showing 70 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- BEAM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1745999
- Former names
- Beam Therapeutics Inc. (until Nov 3, 2026)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.